Nanfang Plus: Huangpu's emerging industries, anti-epidemic fight cited by State Council

Two works of Guangzhou's Huangpu district were cited by the State Council on May 7 and will receive corresponding rewards.

One of them was the district's support for strategic emerging industries, distinctive industrial characteristics and advantages, strong technological innovation capabilities and solid industrial foundations.

As a reward, local key projects will be prioritized to be included in the national key project repository for large-amount and long-term credit support, and have increased quota in the application of innovation platforms such as the national enterprise technology center. National funds for the development of strategic emerging industries will be allocated as sub-funds in Huangpu.

The other cited work is the prominent science and technology-based achievements made by Huangpu in the fight against the COVID-19 pandemic. as well as production resumption.

After the outbreak of the pandemic, Huangpu organized more than 200 local scientific research enterprises and public institutions for emergency response. The AI-aided COVID-19 diagnosis system developed by Guangzhou Regenerative Medicine and Health Guangdong Laboratory (Bioland Laboratory) were promoted nationwide.

Daan Gene and Wondfo Biotech were among the first companies to develop COVID-19 nucleic acid detection kits, and produced more than 40 percent of China's supply. Huangpu-made anti-epidemic supplies were exported to 61 countries and regions, earning two letters of thanks from the State Council's medical supply support group for joint prevention and control.

Rendering of Huangpu's COVID-19 vaccine production base.

Share - WeChat